Tirzepatide 5mg research-grade vial
TELOS — Research Peptides
GLP-1 / GLP-3 Receptor Agonists

Tirzepatide 5mg

Dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Studied for compound incretin signaling and metabolic phenotypes that exceed mono-agonist GLP-1 references.

Category
GLP-1 / GLP-3 Receptor Agonists
Purity
≥98% by HPLC
Form
Lyophilized powder
COA
Available on request
Strength
5mg
Use
For Research Use Only
Request COA / Specs

Submitting a request does not charge a card. Pricing and shipping are confirmed by a team member within one business day.

Quick Facts

Compound
Tirzepatide 5mg
Category
GLP-1 / GLP-3 Receptor Agonists
Typical Purity
≥98% by HPLC
Physical Form
Lyophilized powder
Stability & Handling
Lyophilized; reconstitute with bacteriostatic water; aliquot to limit freeze–thaw; refrigerate working solutions.
Primary Research Focus
Glycemic regulation; lipolysis and lipid handling; comparative incretin pharmacology; preclinical body-composition modeling.
Certificate of Analysis
Available on request
Intended Use
For Research Use Only — laboratory and in vitro work

What it is

Tirzepatide (5mg) is supplied as a lyophilized reference compound for investigators in glp-1 / glp-3 receptor agonists research. Dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Studied for compound incretin signaling and metabolic phenotypes that exceed mono-agonist GLP-1 references.

Within published references, the compound is most often interrogated alongside controls that match its delivery vehicle and reconstitution buffer, with attention to lot-to-lot purity and identity verification before use in any quantitative assay.

Research applications

Documented research applications for Tirzepatide span several preclinical domains. The bullets below summarize commonly cited research questions; they do not constitute claims regarding human use, therapeutic effect, or any clinical outcome.

  • Glycemic regulation — preclinical assay endpoints and pathway-specific readouts.
  • Lipolysis and lipid handling — preclinical assay endpoints and pathway-specific readouts.
  • Comparative incretin pharmacology — preclinical assay endpoints and pathway-specific readouts.
  • Preclinical body-composition modeling — preclinical assay endpoints and pathway-specific readouts.
  • Comparative pharmacology versus the related research compounds listed below, in matched-vehicle preclinical models.
  • Lot-to-lot reproducibility evaluations using HPLC, ESI-MS, and orthogonal functional assays.

Common research focus areas include Glycemic regulation; lipolysis and lipid handling; comparative incretin pharmacology; preclinical body-composition modeling. Investigators routinely use Tirzepatide as a probe for these pathways and as a reference compound in comparative pharmacology against the related research summaries linked at the bottom of this page.

Quality specifications

Reference-grade Tirzepatide is characterized at minimum by reverse-phase HPLC purity (≥98% by HPLC), electrospray-ionization mass spectrometry confirming the expected monoisotopic mass, and quantitative amino-acid analysis where applicable. Cell-culture-grade lots additionally include endotoxin testing by Limulus amebocyte lysate (LAL) assay and bioburden screening. Each lot ships with a Certificate of Analysis itemizing purity, identity, residual solvents, water content (Karl Fischer), and counter-ion content where relevant.

Investigators working with new lots should request raw chromatograms and mass spectra prior to incorporating material into published work, and should validate ELISA or activity-assay readouts against orthogonal mass-spectrometric or functional methods.

Stability & handling

Lyophilized; reconstitute with bacteriostatic water; aliquot to limit freeze–thaw; refrigerate working solutions. Working aliquots in active use are typically held at 2–8 °C for no more than 14 days, and freeze–thaw cycles should be minimized and documented in published methods. Storage history materially affects published phenotype magnitude and should be reported alongside dose and vehicle in any paper using this material.

Compliance & regulatory framing

This material is provided strictly for research and educational reference. The compound is supplied for in vitro investigation and laboratory characterization only and is not intended for human ingestion, injection, topical use, or any clinical application. Federal and state law treats research peptides and small molecules as non-therapeutic chemicals; recipients are responsible for compliance with all applicable institutional, state, and federal regulations governing handling, storage, and disposal. Order requests are reviewed by the research team and quoted privately; pricing, availability, and supply specifications are subject to change without notice.

For Research Use Only. Not for human or veterinary consumption, diagnostic procedures, or therapeutic use. Material is supplied to qualified investigators for laboratory and in vitro work. Recipients are responsible for compliance with all applicable institutional, state, and federal regulations.

Order & Certificate of Analysis

To submit a research-quantity order request or to ask for HPLC chromatograms, mass-spectrometry verification, or lot-specific COA, use the above. A team member will follow up within one business day to confirm pricing, shipping, and any documentation required.

Tirzepatide 5mg

Request Order — Tirzepatide 5mg

Submit your request and a team member will follow up within one business day to confirm pricing, shipping, and any questions before processing. This is not a checkout. No card is charged on this form.

For Research Use Only. Not for human or veterinary consumption.